Depending on the prevalent tumour microenvironment, malignancy-promoting mutations in the components of the NF-κB-signalling cascade, and the inflammatory molecules released by the tumour immune cells, the biological importance of the NF-κB pathway is diverted from the immunosurveillance mechanism towards tumour-promoting functions. This evidence concerns the gene NFKB1 and neoplasm.